DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

GSP Crop Science Limited — Analyst/Investor Meet Para A-XBRL

NSE 53 min ago·18 Sept 2026, 2:18 pm

GSP Crop Science

GSP Crop Science Limited has announced that it will host a meeting with analysts and institutional investors. This event is a routine corporate communication where the company management typically discusses its financial performance, future strategy, and operational outlook with the investment community.

For investors, such meetings provide a crucial opportunity to understand the company's direction beyond what is visible in public filings. It helps gauge management's confidence and offers insights into upcoming projects or challenges that could impact the stock's performance.

Investors should watch for any updates on production targets, export plans, or capital expenditure. Following the event, the company may release a transcript or presentation slides, which will be available on the stock exchange website for detailed review.